Global

June 17, 2020

Digital Adherence Technologies: Technical Guidance & Budget for Global Fund Funding Request

Digital Adherence Technologies: Technical Guidance & Budget for Global Fund Funding Request https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_MobileReminder_v1.jpg 2000 1333 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_MobileReminder_v1.jpg June 17, 2020 September 9, 2020

August 27, 2019

Care of Tuberculosis Patients in Resource-Limited Countries

Care of Tuberculosis Patients in Resource-Limited Countries https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_ResourceImage_v1-scaled.jpg 2560 1707 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_ResourceImage_v1-scaled.jpg August 27, 2019 September 9, 2020

March 15, 2019

ASCPT Presentation: Versatility and Scalability of Solutions to Monitor and Improve Medication Adherence

ASCPT Presentation: Versatility and Scalability of Solutions to Monitor and Improve Medication Adherence https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_LungHealthConf_Abstract_v1.jpg 2000 1333 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_LungHealthConf_Abstract_v1.jpg March 15, 2019 September 9, 2020

March 7, 2019

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_MedicationAbstract_v1.jpg 2000 1500 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_MedicationAbstract_v1.jpg March 7, 2019 September 9, 2020

July 13, 2018

Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives

Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives https://www.thearcadygroup.com/wp-content/uploads/2020/06/TAG_ResourceImage_v9-scaled.jpg 2560 1707 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/06/TAG_ResourceImage_v9-scaled.jpg July 13, 2018 September 9, 2020

April 20, 2018

The impact of digital health technologies on tuberculosis treatment: a systematic review

The impact of digital health technologies on tuberculosis treatment: a systematic review https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_Resource_MedicationReminder_v1.jpg 2000 1333 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_Resource_MedicationReminder_v1.jpg April 20, 2018 September 9, 2020

April 20, 2018

Factors Associated With Non-Adherence to Tuberculosis Treatment in Kenya

Factors Associated With Non-Adherence to Tuberculosis Treatment in Kenya https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_HomeLanding_ChildrenSmiling_v1.jpg 2000 1333 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_HomeLanding_ChildrenSmiling_v1.jpg April 20, 2018 September 9, 2020

September 26, 2017

Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis

Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis https://www.thearcadygroup.com/wp-content/uploads/2020/05/MERM-3.jpeg 1000 899 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/05/MERM-3.jpeg September 26, 2017 September 9, 2020

June 23, 2017

The Tuberculosis Cascade of Care in India’s Public Sector: A Systematic Review and Meta-analysis

The Tuberculosis Cascade of Care in India’s Public Sector: A Systematic Review and Meta-analysis https://www.thearcadygroup.com/wp-content/uploads/2020/07/IMG_6198-scaled.jpg 2560 1707 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/IMG_6198-scaled.jpg June 23, 2017 September 9, 2020

June 23, 2017

Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care

Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_ResourceImage_v6-scaled.jpg 2560 1707 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/07/TAG_ResourceImage_v6-scaled.jpg June 23, 2017 September 9, 2020

Digital Adherence Technologies: Technical Guidance & Budget for Global Fund Funding Request

Care of Tuberculosis Patients in Resource-Limited Countries

ASCPT Presentation: Versatility and Scalability of Solutions to Monitor and Improve Medication Adherence

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine

Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives

The impact of digital health technologies on tuberculosis treatment: a systematic review

Factors Associated With Non-Adherence to Tuberculosis Treatment in Kenya

Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis

The Tuberculosis Cascade of Care in India’s Public Sector: A Systematic Review and Meta-analysis

Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care

Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.

Navigation

Latest Resources

Stay Connected

Global

Digital Adherence Technologies: Technical Guidance & Budget for Global Fund Funding Request

Care of Tuberculosis Patients in Resource-Limited Countries

ASCPT Presentation: Versatility and Scalability of Solutions to Monitor and Improve Medication Adherence

Medicines for All Institute Develops New, Cost-Saving Synthesis of Anti-HIV Drug Emtricitabine

Arcady Group Awarded Grant to Continue TB Medication Adherence Initiatives

The impact of digital health technologies on tuberculosis treatment: a systematic review

Factors Associated With Non-Adherence to Tuberculosis Treatment in Kenya

Usability of a Medication Event Reminder Monitor System (MERM) by Providers and Patients to Improve Adherence in the Management of Tuberculosis

The Tuberculosis Cascade of Care in India’s Public Sector: A Systematic Review and Meta-analysis

Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care

Accelerating the availability and uptake of life-saving technologies and medications for patients who need them most.

Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.